TDP2
Basic information
Region (hg38): 6:24649979-24666930
Previous symbols: [ "TTRAP" ]
Links
Phenotypes
GenCC
Source:
- spinocerebellar ataxia, autosomal recessive 23 (Strong), mode of inheritance: AR
- spinocerebellar ataxia, autosomal recessive 23 (Strong), mode of inheritance: AR
- spinocerebellar ataxia, autosomal recessive 23 (Supportive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Spinocerebellar ataxia, autosomal recessive 23 | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Neurologic | 24658003 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (5 variants)
- Spinocerebellar ataxia, autosomal recessive 23 (2 variants)
- Cerebellar ataxia (1 variants)
- Inborn genetic diseases (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TDP2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 11 | |||||
missense | 26 | 33 | ||||
nonsense | 4 | |||||
start loss | 0 | |||||
frameshift | 4 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
splice region | 1 | 1 | 2 | |||
non coding | 1 | |||||
Total | 8 | 1 | 28 | 15 | 2 |
Highest pathogenic variant AF is 0.0000197
Variants in TDP2
This is a list of pathogenic ClinVar variants found in the TDP2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
6-24650804-A-G | Inborn genetic diseases | Uncertain significance (Oct 12, 2021) | ||
6-24650832-T-C | Inborn genetic diseases | Uncertain significance (Jun 13, 2023) | ||
6-24650833-A-C | Likely benign (Jul 01, 2024) | |||
6-24650843-C-T | Inborn genetic diseases | Uncertain significance (Jun 02, 2023) | ||
6-24650847-A-T | Inborn genetic diseases | Uncertain significance (Mar 07, 2025) | ||
6-24650882-C-T | Inborn genetic diseases | Likely benign (Sep 02, 2024) | ||
6-24650925-T-G | Inborn genetic diseases | Uncertain significance (May 09, 2023) | ||
6-24650927-C-T | Inborn genetic diseases | Uncertain significance (Sep 17, 2021) | ||
6-24650928-G-A | Spinocerebellar ataxia, autosomal recessive 23 | Pathogenic (Jul 29, 2022) | ||
6-24650958-T-C | Benign (Dec 31, 2019) | |||
6-24651017-A-C | not specified | Uncertain significance (Aug 19, 2015) | ||
6-24651027-A-G | Inborn genetic diseases | Uncertain significance (Jan 16, 2024) | ||
6-24653017-A-G | Inborn genetic diseases | Uncertain significance (Nov 13, 2023) | ||
6-24653018-T-C | Likely benign (Jan 01, 2024) | |||
6-24653059-A-T | Inborn genetic diseases | Uncertain significance (May 05, 2023) | ||
6-24653086-G-A | Inborn genetic diseases | Uncertain significance (Mar 23, 2023) | ||
6-24653139-TC-T | Spinocerebellar ataxia, autosomal recessive 23 | Pathogenic (Aug 05, 2020) | ||
6-24653142-T-G | Likely benign (Sep 06, 2017) | |||
6-24653158-A-G | Likely benign (May 10, 2018) | |||
6-24654405-TACTC-T | Cerebellar ataxia | Pathogenic (Jan 28, 2020) | ||
6-24654409-CACAT-C | Spinocerebellar ataxia, autosomal recessive 23 | Likely pathogenic (Aug 11, 2021) | ||
6-24654466-TTG-T | Inborn genetic diseases | Pathogenic (Jul 20, 2023) | ||
6-24654488-G-A | Uncertain significance (Aug 07, 2018) | |||
6-24657814-G-A | Inborn genetic diseases | Uncertain significance (Dec 07, 2021) | ||
6-24657828-A-G | Likely benign (May 01, 2018) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
TDP2 | protein_coding | protein_coding | ENST00000378198 | 7 | 17057 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.13e-8 | 0.552 | 125693 | 0 | 55 | 125748 | 0.000219 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.115 | 183 | 187 | 0.976 | 0.00000886 | 2365 |
Missense in Polyphen | 33 | 47.53 | 0.6943 | 598 | ||
Synonymous | -2.37 | 89 | 64.7 | 1.37 | 0.00000306 | 669 |
Loss of Function | 1.10 | 15 | 20.4 | 0.737 | 0.00000125 | 229 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000336 | 0.000336 |
Ashkenazi Jewish | 0.0000992 | 0.0000992 |
East Asian | 0.000326 | 0.000326 |
Finnish | 0.0000924 | 0.0000924 |
European (Non-Finnish) | 0.000267 | 0.000264 |
Middle Eastern | 0.000326 | 0.000326 |
South Asian | 0.000229 | 0.000229 |
Other | 0.000332 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: DNA repair enzyme that can remove a variety of covalent adducts from DNA through hydrolysis of a 5'-phosphodiester bond, giving rise to DNA with a free 5' phosphate. Catalyzes the hydrolysis of dead-end complexes between DNA and the topoisomerase 2 (TOP2) active site tyrosine residue. The 5'-tyrosyl DNA phosphodiesterase activity can enable the repair of TOP2-induced DNA double-strand breaks/DSBs without the need for nuclease activity, creating a 'clean' DSB with 5'-phosphate termini that are ready for ligation. Thereby, protects the transcription of many genes involved in neurological development and maintenance from the abortive activity of TOP2. Hydrolyzes 5'- phosphoglycolates on protruding 5' ends on DSBs due to DNA damage by radiation and free radicals. Has preference for single-stranded DNA or duplex DNA with a 4 base pair overhang as substrate. Acts as a regulator of ribosome biogenesis following stress. Has also 3'-tyrosyl DNA phosphodiesterase activity, but less efficiently and much slower than TDP1. Constitutes the major if not only 5'- tyrosyl-DNA phosphodiesterase in cells. Also acts as an adapter by participating in the specific activation of MAP3K7/TAK1 in response to TGF-beta: associates with components of the TGF-beta receptor-TRAF6-TAK1 signaling module and promotes their ubiquitination dependent complex formation. Involved in non- canonical TGF-beta induced signaling routes. May also act as a negative regulator of ETS1 and may inhibit NF-kappa-B activation. {ECO:0000269|PubMed:19794497, ECO:0000269|PubMed:21030584, ECO:0000269|PubMed:21921940, ECO:0000269|PubMed:21980489, ECO:0000269|PubMed:22405347, ECO:0000269|PubMed:22822062, ECO:0000269|PubMed:24658003}.;
- Disease
- DISEASE: Spinocerebellar ataxia, autosomal recessive, 23 (SCAR23) [MIM:616949]: A form of spinocerebellar ataxia, a clinically and genetically heterogeneous group of cerebellar disorders due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCAR23 patients manifest epilepsy, intellectual disability, and gait ataxia. {ECO:0000269|PubMed:24658003}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Oxidative Damage;DNA Repair;Nonhomologous End-Joining (NHEJ);DNA Double-Strand Break Repair;CD40/CD40L signaling
(Consensus)
Recessive Scores
- pRec
- 0.122
Intolerance Scores
- loftool
- rvis_EVS
- 1.04
- rvis_percentile_EVS
- 91.26
Haploinsufficiency Scores
- pHI
- 0.826
- hipred
- N
- hipred_score
- 0.380
- ghis
- 0.410
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- H
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.824
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Tdp2
- Phenotype
- hematopoietic system phenotype; normal phenotype; immune system phenotype; digestive/alimentary phenotype; growth/size/body region phenotype; endocrine/exocrine gland phenotype; homeostasis/metabolism phenotype; cellular phenotype;
Zebrafish Information Network
- Gene name
- tdp2b
- Affected structure
- head
- Phenotype tag
- abnormal
- Phenotype quality
- decreased size
Gene ontology
- Biological process
- double-strand break repair;cell surface receptor signaling pathway;neuron development;nucleic acid phosphodiester bond hydrolysis;negative regulation of nucleic acid-templated transcription
- Cellular component
- nucleus;nucleoplasm;nucleolus;cytoplasm;aggresome;nuclear body;PML body
- Molecular function
- magnesium ion binding;single-stranded DNA binding;transcription corepressor activity;nuclease activity;protein binding;manganese ion binding;tyrosyl-RNA phosphodiesterase activity;5'-tyrosyl-DNA phosphodiesterase activity